These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hepatic stellate cells in human schistosomiasis mansoni: a comparative immunohistochemical study with liver cirrhosis. Chang D; Ramalho LN; Ramalho FS; Martinelli AL; Zucoloto S Acta Trop; 2006 Mar; 97(3):318-23. PubMed ID: 16473318 [TBL] [Abstract][Full Text] [Related]
8. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329 [TBL] [Abstract][Full Text] [Related]
9. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy. Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968 [TBL] [Abstract][Full Text] [Related]
10. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Schmitt-Gräff A; Krüger S; Bochard F; Gabbiani G; Denk H Am J Pathol; 1991 May; 138(5):1233-42. PubMed ID: 2024709 [TBL] [Abstract][Full Text] [Related]
11. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis. Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000 [TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy. Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652 [TBL] [Abstract][Full Text] [Related]
13. Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon. García-Buey L; López-Botet M; García-Sánchez A; Balboa MA; Aramburu J; García-Monzón C; Acevedo A; Moreno-Otero R Hepatology; 1993 Mar; 17(3):372-82. PubMed ID: 7680330 [TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis. Akyol G; Erdem O; Yilmaz G Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770 [TBL] [Abstract][Full Text] [Related]
15. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers. Hellerbrand C; Bataille F; Schlegel J; Hartmann A; Mühlbauer M; Schölmerich J; Büttner R; Hofstädter F; Bosserhoff AK Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062 [TBL] [Abstract][Full Text] [Related]
16. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases]. Tomihira M Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742 [TBL] [Abstract][Full Text] [Related]
17. Disease- and cell-specific expression of GP73 in human liver disease. Iftikhar R; Kladney RD; Havlioglu N; Schmitt-Gräff A; Gusmirovic I; Solomon H; Luxon BA; Bacon BR; Fimmel CJ Am J Gastroenterol; 2004 Jun; 99(6):1087-95. PubMed ID: 15180730 [TBL] [Abstract][Full Text] [Related]
18. Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C. El-Karef A; Kaito M; Tanaka H; Ikeda K; Nishioka T; Fujita N; Inada H; Adachi Y; Kawada N; Nakajima Y; Imanaka-Yoshida K; Yoshida T J Hepatol; 2007 Apr; 46(4):664-73. PubMed ID: 17188391 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963 [TBL] [Abstract][Full Text] [Related]
20. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Takahara T; Furui K; Yata Y; Jin B; Zhang LP; Nambu S; Sato H; Seiki M; Watanabe A Hepatology; 1997 Dec; 26(6):1521-9. PubMed ID: 9397993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]